Wifi RT QPCR Machine 2×8 Wells 0.2ml 4 Channels Real Time Thermal Cycler

Real time qPCR machine 16 / 24 machine 2/4 channels thermal cycler amplification PCR instrument

Principle:

The essence of PCR technology is nucleic acid amplification in vitro, heat to uncoil double stranded DNA, hybridize primer with template DNA at annealing temperature, extend primer in the presence of Taq DNA polymerase, dNTPs, Mg2+ and suitable pH buffer, repeat the process of "denaturation → annealing → primer extension" to 25 ~ 40 cycles. Exponentially expand the nucleic acid copy number in the sample to be tested.

Micgene 162/164 Real-time fluorescence quantitative PCR analyzer:

Remark:

Small and exquisite:
Easy to carry, vehicle-mounted, small in size, light in weight, and easy to carry;
Steady light path:
Fixed optical path, no moving parts, means no optical alignment or calibration after moving;
Strong light source:
Each channel has a separate high-intensity LED excitation source, using separate emission filters and detectors;
Warm up fast:
Use magnetic induction technology to achieve heating and forced airflow cooling, faster heating and cooling time;
Temperature control standard:
Rotating aluminum rotors have unmatched temperature uniformity in both dynamic and static operation;

Specification:

Product Details:

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.